4//SEC Filing
O'Brien Stephen Paul 4
Accession 0002064889-25-000003
CIK 0001346830other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 5:00 PM ET
Size
5.8 KB
Accession
0002064889-25-000003
Insider Transaction Report
Form 4
O'Brien Stephen Paul
Principal Accounting Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-12-16+4,000→ 4,000 totalExercise: $4.20Exp: 2035-12-16→ Common Stock (4,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on December 16, 2026, and the balance of the shares subject to the option shall vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continuous service through each applicable vesting date.
Documents
Issuer
Tvardi Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0002064889
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 5:00 PM ET
- Size
- 5.8 KB